ADVERTISEMENT
ADVERTISEMENT
Innovation squeeze worries biotech leaders
Panelists said the future of R&D will depend on integrating new technologies, improving collaboration and maintaining long-term investment in innovation
-
1759953093.png)
Staff Reporter - Thu, 30, Apr 2026
- 17:01 EDT
- 8
Flagship panel: Hard Truths from the Top: What BioPharma R&D Must Do Differently. / USAIC
Boston, April 30: Drugmakers need to change how they pursue innovation, industry leaders said, warning that current funding and development models are not supporting the next wave of breakthroughs.
At a high-level panel on the future of drug research, senior industry executives said the sector faces a difficult balancing act — delivering near-term results while continuing to invest in long-term, high-risk science.
This post is for paying subscribers only
SUBSCRIBE NOW
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login